Search research articles
Contact Us
Filters
Showing results (141-150 of 160) with videos related to
Page
of 16
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 21, 2019
Negative Hyperselection of Patients With <i>RAS</i> and <i>BRAF</i> Wild-Type Metastatic Colorectal Cancer Who Received Panitumumab-Based Maintenance Therapy
Federica Morano, Salvatore Corallo, Sara Lonardi, et al.
JCO Precision Oncology
|
June 11, 2025
Real-World Outcomes of Molecular Tumor Board Treatment Recommendations
Federico Nichetti, Marta Brambilla, Matteo Duca, et al.
Endocrine
|
June 23, 2026
Liquid biopsies for BRAF V600E assessment and monitoring in anaplastic thyroid carcinoma: a real-world study of a tertiary cancer center
Elena Colombo, Elisa Ortolan, Stefano Cavalieri, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 6, 2021
The Added Value of Baseline Circulating Tumor DNA Profiling in Patients with Molecularly Hyperselected, Left-sided Metastatic Colorectal Cancer
Paolo Manca, Salvatore Corallo, Adele Busico, et al.
Clinical Colorectal Cancer
|
December 19, 2018
Perioperative Bevacizumab-based Triplet Chemotherapy in Patients With Potentially Resectable Colorectal Cancer Liver Metastases
Filippo Pietrantonio, Christian Cotsoglou, Giovanni Fucà, et al.
JCO Precision Oncology
|
February 1, 2022
Atypical <i>RAS</i> Mutations in Metastatic Colorectal Cancer
Filippo Pietrantonio, Rona Yaeger, Alexa B Schrock, et al.
Frontiers in Oncology
|
August 22, 2025
Genomic instability and <i>CCNE1</i> amplification as emerging biomarkers for stratifying high-grade serous ovarian cancer
Elena Conca, Daniele Lorenzini, Emanuela Minna, et al.
Journal of Hematology & Oncology
|
December 15, 2023
Safety and antitumor activity of metformin plus lanreotide in patients with advanced gastro-intestinal or lung neuroendocrine tumors: the phase Ib trial MetNET2
Sara Pusceddu, Francesca Corti, Natalie Prinzi, et al.
Science Translational Medicine
|
December 10, 2025
Antigen-agnostic identification of poxvirus broadly neutralizing antibodies targeting OPG153
Ida Paciello, Emily J Rundlet, Ling Zhou, et al.
Cancer Research
|
February 19, 2015
Evolutionary Action Score of TP53 Coding Variants Is Predictive of Platinum Response in Head and Neck Cancer Patients
Abdullah A Osman, David M Neskey, Panagiotis Katsonis, et al.
Page
of 16
Search research articles
Search
Showing results (141-150 of 160) with videos related to
Sort By:
Page
of 16
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 21, 2019
Negative Hyperselection of Patients With <i>RAS</i> and <i>BRAF</i> Wild-Type Metastatic Colorectal Cancer Who Received Panitumumab-Based Maintenance Therapy
Federica Morano, Salvatore Corallo, Sara Lonardi, et al.
JCO Precision Oncology
|
June 11, 2025
Real-World Outcomes of Molecular Tumor Board Treatment Recommendations
Federico Nichetti, Marta Brambilla, Matteo Duca, et al.
Endocrine
|
June 23, 2026
Liquid biopsies for BRAF V600E assessment and monitoring in anaplastic thyroid carcinoma: a real-world study of a tertiary cancer center
Elena Colombo, Elisa Ortolan, Stefano Cavalieri, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 6, 2021
The Added Value of Baseline Circulating Tumor DNA Profiling in Patients with Molecularly Hyperselected, Left-sided Metastatic Colorectal Cancer
Paolo Manca, Salvatore Corallo, Adele Busico, et al.
Clinical Colorectal Cancer
|
December 19, 2018
Perioperative Bevacizumab-based Triplet Chemotherapy in Patients With Potentially Resectable Colorectal Cancer Liver Metastases
Filippo Pietrantonio, Christian Cotsoglou, Giovanni Fucà, et al.
JCO Precision Oncology
|
February 1, 2022
Atypical <i>RAS</i> Mutations in Metastatic Colorectal Cancer
Filippo Pietrantonio, Rona Yaeger, Alexa B Schrock, et al.
Frontiers in Oncology
|
August 22, 2025
Genomic instability and <i>CCNE1</i> amplification as emerging biomarkers for stratifying high-grade serous ovarian cancer
Elena Conca, Daniele Lorenzini, Emanuela Minna, et al.
Journal of Hematology & Oncology
|
December 15, 2023
Safety and antitumor activity of metformin plus lanreotide in patients with advanced gastro-intestinal or lung neuroendocrine tumors: the phase Ib trial MetNET2
Sara Pusceddu, Francesca Corti, Natalie Prinzi, et al.
Science Translational Medicine
|
December 10, 2025
Antigen-agnostic identification of poxvirus broadly neutralizing antibodies targeting OPG153
Ida Paciello, Emily J Rundlet, Ling Zhou, et al.
Cancer Research
|
February 19, 2015
Evolutionary Action Score of TP53 Coding Variants Is Predictive of Platinum Response in Head and Neck Cancer Patients
Abdullah A Osman, David M Neskey, Panagiotis Katsonis, et al.
Page
of 16